Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FFBJ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,203
Award facts
- Contract value 100% obligated
- $13,203.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,203.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. serves as the prime contractor with no identified subcontractor relationships.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V contract authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for federal military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FFBJ8?
SPE2DR26FFBJ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FFBJ8 worth?
The government has obligated $13,203 on SPE2DR26FFBJ8.
Is contract SPE2DR26FFBJ8 an order under another contract?
Yes. SPE2DR26FFBJ8 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBJ8 competed?
The extent of competition for SPE2DR26FFBJ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award